Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Willmore

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Analytical Toxicology|October 7, 2020
Large Differences in Urinary Benzene Metabolite S-Phenylmercapturic Acid Quantitation: A Comparison of Five LC-MS-MS MethodsDenise S Tevis, Andrew Willmore, Deepak Bhandari, et al.
Research Square|August 14, 2023
Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19Lucile P A Neyton, Ravi K Patel, Aartik Sarma, et al.
Nature Communications|June 28, 2024
Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19Lucile P A Neyton, Ravi K Patel, Aartik Sarma, et al.
CHEST Critical Care|October 18, 2024
Elevated Hemoglobin A1c and the Risk of Developing ARDS in Two Cohort StudiesAvery M Bogart, Christine R Lopez, Sarah N Obeidalla, et al.
Immunity|July 2, 2022
Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patientsCassandra E Burnett, Trine Line Hauge Okholm, Iliana Tenvooren, et al.
Immunity|March 28, 2026
NF-κB-activated fibroblasts orchestrate inflammaging and emergence of pro-inflammatory granzyme K<sup>+</sup> T cellsNancy C Allen, Christian Ringler, Sang Ho Woo, et al.
Critical Care (London, England)|April 22, 2024
Rapidly improving ARDS differs clinically and biologically from persistent ARDSPatricia L Valda Toro, Andrew Willmore, Nelson E Wu, et al.
Critical Care Medicine|October 28, 2025
Prognostic Relevance of Inflammatory Subphenotypes in Immunocompromised Patients With SepsisMelanie F Weingart, Andrew Willmore, Hanjing Zhuo, et al.
Critical Care (London, England)|September 14, 2022
Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19Katherine D Wick, Aleksandra Leligdowicz, Andrew Willmore, et al.
Medrxiv : the Preprint Server for Health Sciences|September 18, 2025
Longitudinal multi-omic signatures of ARDS and sepsis inflammatory phenotypes identify key pathways associated with mortalityNarges Alipanah-Lechner, Lucile Neyton, Pratik Sinha, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Analytical Toxicology|October 7, 2020
Large Differences in Urinary Benzene Metabolite S-Phenylmercapturic Acid Quantitation: A Comparison of Five LC-MS-MS MethodsDenise S Tevis, Andrew Willmore, Deepak Bhandari, et al.
Research Square|August 14, 2023
Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19Lucile P A Neyton, Ravi K Patel, Aartik Sarma, et al.
Nature Communications|June 28, 2024
Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19Lucile P A Neyton, Ravi K Patel, Aartik Sarma, et al.
CHEST Critical Care|October 18, 2024
Elevated Hemoglobin A1c and the Risk of Developing ARDS in Two Cohort StudiesAvery M Bogart, Christine R Lopez, Sarah N Obeidalla, et al.
Immunity|July 2, 2022
Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patientsCassandra E Burnett, Trine Line Hauge Okholm, Iliana Tenvooren, et al.
Immunity|March 28, 2026
NF-κB-activated fibroblasts orchestrate inflammaging and emergence of pro-inflammatory granzyme K<sup>+</sup> T cellsNancy C Allen, Christian Ringler, Sang Ho Woo, et al.
Critical Care (London, England)|April 22, 2024
Rapidly improving ARDS differs clinically and biologically from persistent ARDSPatricia L Valda Toro, Andrew Willmore, Nelson E Wu, et al.
Critical Care Medicine|October 28, 2025
Prognostic Relevance of Inflammatory Subphenotypes in Immunocompromised Patients With SepsisMelanie F Weingart, Andrew Willmore, Hanjing Zhuo, et al.
Critical Care (London, England)|September 14, 2022
Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19Katherine D Wick, Aleksandra Leligdowicz, Andrew Willmore, et al.
Medrxiv : the Preprint Server for Health Sciences|September 18, 2025
Longitudinal multi-omic signatures of ARDS and sepsis inflammatory phenotypes identify key pathways associated with mortalityNarges Alipanah-Lechner, Lucile Neyton, Pratik Sinha, et al.
Pageof 3